Sanford Health Selects GenomeNext to Provide Enterprise Genomic Analysis Platform for Personalized Medicine Programs
COLUMBUS, Ohio–(BUSINESS WIRE)–GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that Sanford Health, a Dakotas-based non-profit health system, and one of the largest integrated health systems in the nation, has selected GenomeNext’s Olympus Platform to deliver comprehensive genomic analysis and data management capabilities to expand its personalized medicine program across multiple U.S. regions to individualize patient treatment and improve health outcomes throughout the Sanford Health enterprise.
Sanford Imagenetics is a comprehensive genomic medicine initiative launched in 2014 that aims to fully integrate the tools of genomic medicine into primary care for adults. This unique model uses each patient’s family history and genetic makeup to personalize treatment.
“Our goal is to provide precision medicine through Sanford Imagenetics so that our physicians are able to provide both personalized care and effective population health management for all Sanford Health patients as part of routine primary care,” said Cornelius F. Boerkoel, MD, PhD, Executive Director, Sanford Imagenetics Research Center on Genomic & Molecular Medicine and Executive Clinical Director, Sanford Genetics Laboratories.
GenomeNext enables intelligent translational bioinformatics through it’s revolutionary Olympus ‘omics platform; a turnkey, automated, infrastructure solution operating at peta-byte scale that completely eliminates the need to build or architect modular solutions to effectively process genomic data.
The Olympus Platform delivers a true end-to-end, fully integrated genomic analysis solution, requiring no bioinformatic investment, engineering or maintenance, providing seamless workflow and data management from sequencing instrument through analysis, interpretation and storage, including big data genetic association and multivariate analytic capabilities.
James Hirmas, CEO at GenomeNext stated, “We are very excited to work with Sanford to provide a dynamic, holistic NGS analytical platform to accelerate and enhance their innovative approach to introduce genetic testing to clinical practice. The GenomeNext Olympus Platform’s ability to provide unprecedented data quality and speed to diagnosis will significantly contribute to Sanford being able to positively impact and improve patient care.”
GenomeNext’s Olympus Platform will seamlessly interface with Sanford Health’s EPIC electronic health record and LIMS laboratory information management systems to create a continuous, integrated and fully automated solution to scale and manage Sanford’s personalized medicine initiatives.
About Sanford Health
Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 43 hospitals and nearly 250 clinics in nine states and four countries. Sanford Health’s 27,000 employees, including 1,400 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford have allowed for several initiatives, including global children’s clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. Sanford Health recently received the Pontifical Key Innovation award, recognizing their game-changing medical innovation exemplified by transformative thinking, creativity and ingenuity used to deliver the highest quality of medical care. For more information, visit www.sanfordhealth.org.
About GenomeNext – GenomeNext is a genomic informatics company dedicated to accelerating the promise and capability of predictive medicine and scientific discovery. We commercialize genomic analysis tools and integrated systems for the evaluation of genetic variation and function. Our advanced informatics and data management solutions are designed to simplify, expedite and enhance genetic analysis workflows. Our solutions provide the market with genomic data and analysis at an unprecedented combination of performance, quality, cost and scale without requiring the investment in high-performance computing resources and specialized personnel. For more information, visit www.genomenext.com.
Genomics Simplified™
© 2016 GenomeNext, LLC. GenomeNext is a trademark of GenomeNext, LLC. All rights reserved
